By Sabela Ojea
Spectral AI said Michael DiMaio is taking back the chairman of the board position.
The Dallas-based predictive AI company focused on medical diagnostics on Monday said that the board concluded it needed DiMaio's expertise to lead the next stage of growth of the company.
"Our focus will be on commercialization, Food and Drug Administration approval, our exceptional relationship with the Biomedical Advanced Research and Development Authority, and developing key strategic relationships," DiMaio said.
DiMaio is founded Spectral AI in 2009, served as the chief executive officer and chairman from 2011 to 2020. He is also company's second-largest shareholder.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
October 14, 2024 16:19 ET (20:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。